Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,157 | -$34,101 | -$48,588 | -$36,794 |
| Dep. & Amort. | $1,322 | $1,351 | $1,347 | $685 |
| Deferred Tax | $0 | $0 | $0 | $19 |
| Stock-Based Comp. | $3,135 | $4,454 | $5,812 | $5,657 |
| Change in WC | -$489 | -$4,330 | $1,008 | $117 |
| Other Non-Cash | $1,519 | $603 | $1,395 | $57 |
| Operating Cash Flow | -$24,670 | -$32,023 | -$39,026 | -$30,259 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$146 | -$180 | -$321 | -$2,026 |
| Net Acquisitions | $0 | $166 | $15 | $318 |
| Inv. Purchases | -$44,595 | -$21,149 | -$46,869 | -$183,669 |
| Inv. Sales/Matur. | $67,181 | $59,575 | $97,124 | $42,259 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $22,440 | $38,412 | $49,949 | -$143,118 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$811 | -$761 | -$629 | -$255 |
| Stock Issued | $34 | $48 | $342 | $140,594 |
| Stock Repurch. | $0 | -$10,384 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$10 | -$28 | $0 | $23,601 |
| Financing Cash Flow | -$787 | -$11,173 | -$287 | $163,940 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,017 | -$4,784 | $10,636 | -$9,437 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,011 | $17,795 | $7,159 | $16,596 |
| End Cash | $9,994 | $13,011 | $17,795 | $7,159 |
| Free Cash Flow | -$24,816 | -$32,203 | -$39,347 | -$32,285 |